ABCA1 and atherosclerosis: Thus, inhibition of miR-33 increases cholesterol transport from macrophages to plasma, liver, and feces by more than 80%, which can prevent foam cell formation and atherosclerosis by increasing ATP-binding cassette transporters A1 activity and, as a result, increasing HDL levels.